Financials data is unavailable for this security.
View more
Year on year Becton Dickinson and Co grew revenues 4.16% from 19.37bn to 20.18bn while net income improved 16.31% from 1.48bn to 1.73bn.
Gross margin | 45.36% |
---|---|
Net profit margin | 8.56% |
Operating margin | 12.02% |
Return on assets | 3.14% |
---|---|
Return on equity | 6.68% |
Return on investment | 3.66% |
More ▼
Cash flow in USDView more
In 2024, Becton Dickinson and Co increased its cash reserves by 25.32%, or 375.00m. The company earned 3.80bn from its operations for a Cash Flow Margin of 18.82%. In addition the company generated 2.09bn cash from financing while 5.51bn was spent on investing.
Cash flow per share | 13.81 |
---|---|
Price/Cash flow per share | 16.24 |
Book value per share | 89.64 |
---|---|
Tangible book value per share | -39.69 |
More ▼
Balance sheet in USDView more
Current ratio | 1.17 |
---|---|
Quick ratio | 0.7405 |
Total debt/total equity | 0.7761 |
---|---|
Total debt/total capital | 0.437 |
More ▼
Growth rates in USD
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 4.40% and 16.36%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg) | 1.46% |
---|---|
Div growth rate (5 year) | 4.29% |
Payout ratio (TTM) | 47.80% |
EPS growth(5 years) | 9.57 |
---|---|
EPS (TTM) vs TTM 1 year ago | 16.00 |
More ▼